木月皿2015-12-07 06:42
回复@踏血寻踪: 谢谢你的分析。乙肝的试验应该是最值得关注的,那一例面瘫导致了股价的一蹶不振。虽然谈数据还为时太早,但公司能重启乙肝试验就意味着这个药还有希望。明年1月份的两项2期数据是比较被忽略的,即使阳性也有可能股价飙升一下再回落。所以在现阶段$TETRALOGIC PHARMACEUTICALS(TLOG)...查看全文
wfan20222015-07-17 18:16
$TETRALOGIC PHARMACEUTICALS(TLOG)$ PNAS重大成果:乙肝治愈现曙光
2015-04-21 来源 佚名
澳大利亚的科学家们发现了一种针对乙型肝炎病毒(HBV)感染的潜在治愈方法,在临床前模型中这种有前景的新疗法100%成功消除了感染。
现在澳大利亚的一些患者在墨尔本、珀斯和阿德莱德开展的1/2a期...查看全文
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-02-01,10% Owner,Clarus Lifesciences II, L.P. ,卖出,140000普通股, $0.20
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-01-29,10% Owner,Clarus Lifesciences II, L.P. ,卖出,52826普通股, $0.26
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-01-29 AccNo: 0001104659-16-092214 Size: 19 KBItem 7.01: Regulation FD Disclosure 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-01-28,10% Owner,Clarus Lifesciences II, L.P. ,卖出,32521普通股, $0.26
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-01-27,10% Owner,Clarus Lifesciences II, L.P. ,卖出,209984普通股, $0.27
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 内部交易: 2016-01-26,10% Owner,Clarus Lifesciences II, L.P. ,卖出,69425普通股, $0.30
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-01-25 AccNo: 0001104659-16-091115 Size: 20 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-01-22 AccNo: 0001157523-16-004257 Size: 28 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Off...
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2016-01-11 AccNo: 0001157523-16-004181 Size: 18 KBItem 8.01: Other Events 网页链接
$TETRALOGIC PHARMACEUTICALS(TLOG)$ 8-K - Current report Filed: 2015-12-09 AccNo: 0001157523-15-004005 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:/...